Connection

STEVEN SCHERER to Cytochrome P-450 CYP2D6

This is a "connection" page, showing publications STEVEN SCHERER has written about Cytochrome P-450 CYP2D6.
Connection Strength

0.594
  1. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022 05; 24(5):1062-1072.
    View in: PubMed
    Score: 0.195
  2. Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing? J Mol Diagn. 2022 03; 24(3):253-261.
    View in: PubMed
    Score: 0.192
  3. Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes. Nat Commun. 2018 02 26; 9(1):828.
    View in: PubMed
    Score: 0.147
  4. Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic. Pharmacogenomics. 2024; 25(16-18):637-645.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.